Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Betamethasone valerate
Drug ID BADD_D00262
Description Betamethasone is a long-acting corticosteroid with immunosuppressive and antiinflammatory properties.[A192444] It can be used topically to manage inflammatory skin conditions such as eczema, and parenterally to manage several disease states including autoimmune disorders.[A192444] Betamethasone has potent glucocorticoid activity and negligible mineralocorticoid activity.[A192444]
Indications and Usage Systemic use: for the treatment of edocrine disorders, rheumatic disorders, collagen diseases, dermatological diseases, allergic states, ophthalmic diseases, respiratory diseases, hematologic disorders, neoplastic diseases, edematous states, gastrointestinal diseases, tuberculous meningitis and trichinosis.
Marketing Status Prescription; Discontinued
ATC Code A07EA04; C05AA05; D07AC01; D07XC01; H02AB01; R01AD06; R03BA04; S01BA06; S01CB04; S02BA07; S03BA03
DrugBank ID DB00443
KEGG ID D01357
MeSH ID D001624
PubChem ID 16533
TTD Drug ID D03SXE
NDC Product Code 46439-8711; 50090-1647; 68071-5224; 70518-3137; 50090-4696; 63187-276; 0378-8187; 51672-1269; 68788-7451; 53002-9211; 0472-0371; 38779-0004; 65089-0031; 52128-162; 22552-0005; 0168-0040; 53002-9210; 51552-0023; 63187-687; 0713-0327; 51927-1160; 68071-2334; 45802-053; 0168-0041; 68071-4441; 68071-4278; 0472-0370; 53002-8450; 49452-1080; 71205-364; 0378-8180; 68788-7827; 0168-0033; 50090-3134; 50090-3794; 71205-040; 54879-004; 51672-4188; 50742-315; 0713-0326
Synonyms Betamethasone Valerate | Valerate, Betamethasone | Betamethasone 17-Valerate | 17-Valerate, Betamethasone | Betamethasone 17 Valerate | Flubenisolonvalerate | Betnovate
Chemical Information
Molecular Formula C27H37FO6
CAS Registry Number 2152-44-5
SMILES CCCCC(=O)OC1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)C(=O)CO
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Acne23.02.01.001--Not Available
Alopecia23.02.02.001--
Burning sensation17.02.06.001; 08.01.09.029--Not Available
Conjunctivitis06.04.01.002; 11.01.06.012--
Cushing's syndrome24.08.04.001; 19.07.03.002; 14.11.01.007; 05.01.01.001--Not Available
Dermatitis23.03.04.002--Not Available
Dermatitis acneiform23.02.01.004--
Dermatitis contact10.01.01.003; 23.03.04.004; 12.03.01.040--Not Available
Dry skin23.03.03.001--
Endocrine disorder05.09.01.001--Not Available
Erythema23.03.06.001--Not Available
Folliculitis23.09.04.007; 11.01.12.018--
Hypersensitivity10.01.03.003--
Hypertrichosis23.02.04.002--
Immune system disorder10.02.01.001--Not Available
Infection11.01.08.002--Not Available
Leukoderma23.05.02.001--Not Available
Miliaria23.02.03.014--Not Available
Paraesthesia17.02.06.005--
Pruritus23.03.12.001--
Pustular psoriasis23.03.14.006--Not Available
Rash follicular23.03.10.001--Not Available
Skin atrophy23.01.05.001--
Skin disorder23.03.03.007--Not Available
Skin hypopigmentation23.05.02.003--
Skin irritation23.03.04.009--Not Available
Skin striae23.01.05.002--Not Available
Telangiectasia24.03.03.003; 23.06.03.001--
Skin maceration23.03.03.016--Not Available
The 1th Page    1    Total 1 Pages